Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

JCO precision oncology·2026
Same author

Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomas.

Cancer cytopathology·2026
Same author

The complementary roles of endobronchial ultrasound-guided needle aspiration, mini-forceps, and cryobiopsy in the investigation of mediastinal lesions.

Annals of the American Thoracic Society·2026
Same author

Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1/CPS1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations Rather Than Hepatoid Differentiation.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Primary Pulmonary Ameloblastoma: First Case Series With Clinicopathologic and Genomic Analysis.

The American journal of surgical pathology·2026
Same author

What is new for 2026: Challenges & updates in pulmonary pathology.

Human pathology·2025
Same journal

TRPS1 and GATA3 Expression in BRG1/SMARCA4-deficient Malignant Neoplasms.

Human pathology·2026
Same journal

Clinicopathologic and Molecular Characteristics of Acral Melanomas Harboring RARA Fusions.

Human pathology·2026
Same journal

Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

Human pathology·2026
Same journal

Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

Human pathology·2026
Same journal

Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

Human pathology·2026
Same journal

Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

Human pathology·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.1K

RUNX2 (6p21.1) amplification in osteosarcoma.

Sounak Gupta1, Tatsuo Ito2, Deepu Alex2

  • 1Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10065; Current Institutional Affiliation: Mayo Clinic, Rochester, MN, USA, 55905.

Human Pathology
|November 1, 2019
PubMed
Summary
This summary is machine-generated.

Amplification at the 6p12-21 locus is common in osteosarcoma. Fluorescence in situ hybridization targeting RUNX2 is a practical diagnostic method for identifying this alteration and potential therapeutic targets.

Keywords:
6p126p21AmplificationOsteosarcomaRUNX2

More Related Videos

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.9K
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.1K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.9K
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.9K

Area of Science:

  • Oncology
  • Genetics
  • Cancer Genomics

Background:

  • Cytogenetic studies suggest 6p12-21 locus amplifications are frequent in osteosarcoma.
  • Previous research was limited by methodology and sample size.

Purpose of the Study:

  • To accurately determine the frequency of 6p12-21 locus amplification in osteosarcoma.
  • To evaluate RUNX2 as a diagnostic marker for this amplification.

Main Methods:

  • 111 osteosarcomas analyzed using next-generation sequencing (NGS) for copy number alterations.
  • Fluorescence in situ hybridization (FISH) used to assess RUNX2 copy number status.

Main Results:

  • NGS identified 6p12-21 amplification in 21.6% (24/111) of osteosarcoma cases.
  • FISH confirmed RUNX2 within the amplified locus in 94.4% (17/18) of these cases.

Conclusions:

  • 6p12-21 amplification is a significant finding in osteosarcoma.
  • FISH for RUNX2 is a viable diagnostic approach for identifying this amplification, potentially guiding targeted therapies.